O. Basaran Et Al. , "LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY," 87th Congress of the European-Atherosclerosis-Society (EAS) , vol.287, Maastricht, Netherlands, 2019
Basaran, O. Et Al. 2019. LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY. 87th Congress of the European-Atherosclerosis-Society (EAS) , (Maastricht, Netherlands).
Basaran, O., Dogan, V., Mert, G. Ö., Mert, K. U., Ozlek, B., Celik, O., ... Ozlek, E.(2019). LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY . 87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands
Basaran, O. Et Al. "LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY," 87th Congress of the European-Atherosclerosis-Society (EAS), Maastricht, Netherlands, 2019
Basaran, O. Et Al. "LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY." 87th Congress of the European-Atherosclerosis-Society (EAS) , Maastricht, Netherlands, 2019
Basaran, O. Et Al. (2019) . "LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY." 87th Congress of the European-Atherosclerosis-Society (EAS) , Maastricht, Netherlands.
@conferencepaper{conferencepaper, author={O. Basaran Et Al. }, title={LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY}, congress name={87th Congress of the European-Atherosclerosis-Society (EAS)}, city={Maastricht}, country={Netherlands}, year={2019}}